Table I.

Issues to be Considered When Evaluating Options for Anti‐Hemophilic Factor Concentrate

Efficacy

Safety

Antibody provacation

Microbiological

Ease of reconstitution

Ease of administration

Cost and affordability

Availability/accessibility

This article is being made freely available through PubMed Central as part of the COVID-19 public health emergency response. It can be used for unrestricted research re-use and analysis in any form or by any means with acknowledgement of the original source, for the duration of the public health emergency.